Correlation Between Compagnie and Sanofi SA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Compagnie and Sanofi SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Compagnie and Sanofi SA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Compagnie de Saint Gobain and Sanofi SA, you can compare the effects of market volatilities on Compagnie and Sanofi SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Compagnie with a short position of Sanofi SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Compagnie and Sanofi SA.

Diversification Opportunities for Compagnie and Sanofi SA

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Compagnie and Sanofi is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Compagnie de Saint Gobain and Sanofi SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sanofi SA and Compagnie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Compagnie de Saint Gobain are associated (or correlated) with Sanofi SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sanofi SA has no effect on the direction of Compagnie i.e., Compagnie and Sanofi SA go up and down completely randomly.

Pair Corralation between Compagnie and Sanofi SA

Assuming the 90 days trading horizon Compagnie de Saint Gobain is expected to generate 1.06 times more return on investment than Sanofi SA. However, Compagnie is 1.06 times more volatile than Sanofi SA. It trades about 0.09 of its potential returns per unit of risk. Sanofi SA is currently generating about 0.03 per unit of risk. If you would invest  5,288  in Compagnie de Saint Gobain on November 19, 2024 and sell it today you would earn a total of  4,468  from holding Compagnie de Saint Gobain or generate 84.49% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.8%
ValuesDaily Returns

Compagnie de Saint Gobain  vs.  Sanofi SA

 Performance 
       Timeline  
Compagnie de Saint 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Compagnie de Saint Gobain are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Compagnie may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Sanofi SA 

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Sanofi SA are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sanofi SA sustained solid returns over the last few months and may actually be approaching a breakup point.

Compagnie and Sanofi SA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Compagnie and Sanofi SA

The main advantage of trading using opposite Compagnie and Sanofi SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Compagnie position performs unexpectedly, Sanofi SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sanofi SA will offset losses from the drop in Sanofi SA's long position.
The idea behind Compagnie de Saint Gobain and Sanofi SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk